Sight Sciences, Inc. revenue for the last year amounted to 81.06 M USD, the most of which — 74.31 M USD — came from its highest performing source at the moment, Surgical Glaucoma, the year earlier bringing 65.59 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sight Sciences, Inc. 81.06 M USD, and the year before that — 71.33 M USD.